Galileo55 for Improved Cancer Treatment

NASA Mars Rover

Galileo55 by Atomic Oncology, uses technology similar to that on the latest Mars Rover, to provide unprecedented insights into what makes tumors responsive to radiation treatment, or resistant to it. This will allow cancer patients to receive truly personalized radiation treatments from their physicians.

The commercial edge that Galileo55 brings to the table is that it is a first-in-class, multilevel view of the most dangerous attributes of a tumor and its most vulnerable points to attack.